A review of acellular immersion tests on bioactive glasses––influence of medium on ion release and apatite formation
Source abstract
Abstract
Abstract When evaluating new bioactive glass compositions for their suitability as a biomaterial, one of the first steps is the study of their behavior in contact with aqueous solutions. Ion release, pH changes, and apatite precipitation are investigated during immersion experiments, and a wide variety of solutions is used, including simulated body fluid, Tris buffer solution, various cell culture medium formulations or deionized water. This paper reviews the different parameters used for immersion experiments on bioactive glasses. Results show that, depending on solution composition, pH, and buffering capacity, the experimental outcome is likely to vary. In addition, bioactive glass particle size and solution volume/glass surface area ratio affect the resulting ion concentration in solution, and, thus, the rate at which apatite is formed. It is, therefore, important to consider these effects when planning experiments, interpreting results or comparing the results of experiments performed in different laboratories.
Source: crossref · Quality: baseline
Research context
OpenAlex topics: Bone Tissue Engineering Materials · Dental Implant Techniques and Outcomes · Dental materials and restorations
SciVX discovery tags are terminology-based. OpenAlex topics are source-provided classifications.
Affiliations
Department of Mining and Materials Engineering McGill University Montréal QC Canada
Johan Gadolin Process Chemistry Centre Åbo Akademi University Turku Finland
Department of Glass and Ceramics University of Chemistry and Technology Prague Czech Republic
Otto Schott Institute of Materials Research Friedrich Schiller University Jena Jena Germany
References (64)
Show source-provided references
1. The story of Bioglass®10.1007/s10856-006-0432-z ↗
2. Effect of bioactive glass particle size on osseous regeneration of cancellous defects10.1002/(SICI)1097-4636(19980915)41:4<527::AID-JBM3>3.0.CO;2-E ↗
3. A prospective randomized 14‐year follow‐up study of bioactive glass and autogenous bone as bone graft substitutes in benign bone tumors10.1002/jbm.b.31636 ↗
4. The use of advanced diffraction methods in the study of the structure of a bioactive calcia: silica sol‐gel glass10.1007/s10856-006-0436-8 ↗
5. Theoretical analysis of calcium phosphate precipitation in simulated body fluid10.1016/j.biomaterials.2004.05.034 ↗
6. Solutions able to reproduce in vivo surface‐structure changes in bioactive glass‐ceramic A‐W310.1002/jbm.820240607 ↗
7. Fluoride‐containing bioactive glasses: Surface reactivity in simulated body fluids solutions10.1016/j.actbio.2009.06.009 ↗
8. Surface properties and ion release from fluoride‐containing bioactive glasses promote osteoblast differentiation and mineralization in vitro10.1016/j.actbio.2012.10.043 ↗
9. Fluoride‐containing bioactive glasses and Bioglass® 45S5 form apatite in low pH cell culture medium10.1016/j.matlet.2013.12.102 ↗
10. On the dissolution/reaction of small‐grain Bioglass® 45S5 and F‐modified bioactive glasses in artificial saliva (AS)10.1016/j.apsusc.2010.12.019 ↗
11. Fluoride‐containing bioactive glasses: effect of glass design and structure on degradation, pH and apatite formation in simulated body fluid10.1016/j.actbio.2010.01.043 ↗
12. Effect of degradation rates of resorbable phosphate invert glasses on in vitro osteoblast proliferation10.1002/jbm.a.30610 ↗
13. How useful is SBF in predicting in vivo bone bioactivity?10.1016/j.biomaterials.2006.01.017 ↗
14. Apatite‐formation ability – Predictor of “bioactivity”?10.1016/j.actbio.2010.05.013 ↗
15. Can bioactivity be tested in vitro with SBF solution?10.1016/j.biomaterials.2009.01.008 ↗
16. A unified in vitro evaluation for apatite‐forming ability of bioactive glasses and their variants10.1007/s10856-015-5403-9 ↗
17. Calcium carbonate: adored and ignored in bioactivity assessment10.1016/j.actbio.2019.04.039 ↗
18. Buffering systems in the mouth10.1016/0030-4220(55)90241-3 ↗
19. In vivo predictive dissolution: transport analysis of the CO2, bicarbonate in vivo buffer system10.1002/jps.24108 ↗
20. Direct chemical bond of bioactive glass‐ceramic materials to bone and muscle10.1002/jbm.820070304 ↗
21. Effect of pH and ionic strength on the reactivity of Bioglass® 45S510.1016/j.biomaterials.2004.07.009 ↗
22. Dependence on pH of decomposition of glasses by aqueous solutions
23. On determining chemical durability of glasses
24. Influence of dissolution medium pH on ion release and apatite formation of Bioglass® 45S510.1016/j.matlet.2014.12.124 ↗
25. Surface modifications of bioglass immersed in TRIS‐buffered solution. A multitechnical spectroscopic study10.1021/jp050705t ↗
26. An analytical model for the dissolution of different particle size samples of Bioglass® in TRIS‐buffered solution10.1016/j.biomaterials.2005.01.013 ↗
27. Auger spectroscopic analysis of Bioglass corrosion films10.1111/j.1151-2916.1976.tb09382.x ↗
28. Influence of strontium for calcium substitution in bioactive glasses on degradation, ion release and apatite formation10.1098/rsif.2011.0387 ↗
29. The role of MgO on thermal properties, structure and bioactivity of bioactive glass coating for dental implants10.1016/j.jnoncrysol.2012.07.039 ↗
30. High phosphate content significantly increases apatite formation of fluoride‐containing bioactive glasses10.1016/j.actbio.2010.11.037 ↗
31. Iler RK · 1979
32. Elliott JC · 1994
33. Dissolution of bioactive glasses in acidic solutions with the focus on lactic acid10.1111/ijag.12198 ↗
34. Effect of chloride ions in Tris buffer solution on bioactive glass apatite mineralization10.1111/ijag.12288 ↗
35. Dissolution patterns of biocompatible glasses in 2‐amino‐2‐hydroxymethyl‐propane‐1,3‐diol (Tris) buffer10.1016/j.actbio.2012.08.051 ↗
36. Influence of zinc and magnesium substitution on ion release from Bioglass 45S5 at physiological and acidic pH10.1515/bglass-2015-0009 ↗
37. The influence of simulated body fluid composition on carbonated hydroxyapatite formation
38. A study of the formation of amorphous calcium phosphate and hydroxyapatite on melt quenched Bioglass® using surface sensitive shallow angle X‐ray diffraction10.1007/s10856-008-3661-5 ↗
39. Solution effects on the surface reactions of a bioactive glass10.1002/jbm.820270405 ↗
40. Magnesium‐containing carbonate apatites10.1016/S0162-0134(96)00145-6 ↗
41. Inhibitory effect of magnesium and zinc on crystallization kinetics of hydroxyapatite (0001) face10.1021/jp9939726 ↗
42. Apatite formation of substituted Bioglass 45S5: SBF vs. Tris10.1016/j.matlet.2019.126760 ↗
43. In situ Raman spectroscopy investigation of bioactive glass reactivity: Simulated body fluid solution vs TRIS‐buffered solution10.1016/j.matchar.2011.07.008 ↗
44. Influence of fluid circulation on in vitro reactivity of bioactive glass particles10.1016/j.matchemphys.2008.04.055 ↗
45. In vitro dissolution of melt‐derived 45S5 and sol‐gel derived 58S bioactive glasses10.1002/jbm.10207 ↗
46. Apatite formation of bioactive glasses is enhanced by low additions of fluoride but delayed in the presence of serum proteins10.1016/j.matlet.2015.04.013 ↗
47. Influence of cell culture medium composition on in vitro dissolution behavior of a fluoride‐containing bioactive glass10.1002/jbm.a.34724 ↗
48. 45S5 Bioactive glass surface charge variations and the formation of a surface calcium phosphate layer in a solution containing fibronectin10.1002/1097-4636(20010305)54:3<454::AID-JBM200>3.0.CO;2-H ↗
49. Spectroscopic studies of the effect of the metal ions on the structure of mucin10.1016/j.molstruc.2008.10.014 ↗
50. Tough and strong porous bioactive glass‐PLA composites for structural bone repair10.1007/s10853-017-0777-3 ↗
51. Melt electrospinning writing of defined scaffolds using polylactide‐poly(ethylene glycol) blends with 45S5 bioactive glass particles10.1016/j.matlet.2017.06.096 ↗
52. In vitro degradation and bioactivity of composite poly‐l‐lactic (PLLA)/bioactive glass (BG) scaffolds: comparison of 45S5 and 1393BG compositions10.1007/s10853-017-1743-9 ↗
53. Changes in the hydrogen ion concentration of healing fractures10.3181/00379727-61-15256 ↗
54. Influence of surface porosity and pH on bacterial adherence to hydroxyapatite and biphasic calcium phosphate bioceramics10.1099/jmm.0.002758-0 ↗
55. Mineralization and pH relationships in healing skeletal defects grafted with demineralized bone matrix10.1002/jbm.820281209 ↗
56. Dose‐dependent behavior of bioactive glass dissolution10.1002/jbm.10053 ↗
57. Controlling the ion release from mixed alkali bioactive glasses by varying modifier ionic radii and molar volume10.1039/C5TB02426A ↗
58. Influence of strontium and the importance of glass chemistry and structure when designing bioactive glasses for bone regeneration10.1016/j.actbio.2010.01.006 ↗
59. 45S5 Bioglass®‐derived glass–ceramic scaffolds for bone tissue engineering10.1016/j.biomaterials.2005.11.025 ↗
60. Sintering and concomitant crystallisation of bioactive glasses10.1111/ijag.13477 ↗
61. Bioactivity modulation of Bioglass® powder by thermal treatment10.1016/j.jeurceramsoc.2012.03.018 ↗
62. TRIS buffer in simulated body fluid distorts the assessment of glass‐ceramic scaffold bioactivity10.1016/j.actbio.2011.02.028 ↗
63. Interaction of HEPES buffer with glass‐ceramic scaffold: can HEPES replace TRIS in SBF?10.1002/jbm.b.33818 ↗
64. HorkavcováD RohanováD SchuhladenK StříbnýA BoccacciniAR BezdičkaP.Interaction of MOPS buffer with glass‐ceramic scaffold: effect of (PO4)3‐ ions in SBF on kinetics and morphology of formatted hydroxyapatite. Submitted.2019.10.1002/jbm.b.34530 ↗